Literature DB >> 16531042

Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers.

Roberta B Ness1, Francesmary Modugno.   

Abstract

Chronic inflammation has been implicated in a variety of cancers. In this review, we consider associations between endometriosis and cancers both local (ovarian) and distant (breast). We review the epidemiological data linking endometriosis to ovarian and breast cancers. We then consider evidence for a role for sex steroid hormones and for inflammation in the aetiology of each of these cancers. Finally, we consider that endometriosis may promote alterations in sex steroid hormones and inflammatory mediators. A possible explanation for the association between endometriosis and these reproductive cancers may then be local and systemic enhancement of aberrant inflammatory and hormonal mediators. If this hypothesis is true, endometriosis may need to be considered as a risk factor for ovarian and breast cancers, triggering increasingly intensive surveillance. Moreover, treatments for endometriosis may require consideration of the impact on long-term cancer risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531042     DOI: 10.1016/j.ejca.2006.01.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

1.  Basal and steroid hormone-regulated expression of CXCR4 in human endometrium and endometriosis.

Authors:  Abigail Ruiz; Virgilio A Salvo; Lynnette A Ruiz; Perla Báez; Miosotis García; Idhaliz Flores
Journal:  Reprod Sci       Date:  2010-08-18       Impact factor: 3.060

2.  Endometriosis Located Proximal to or Remote From the Uterus Differentially Affects Uterine Gene Expression.

Authors:  Hanyia Naqvi; Ramanaiah Mamillapalli; Graciela Krikun; Hugh S Taylor
Journal:  Reprod Sci       Date:  2015-10-28       Impact factor: 3.060

3.  Identification of common mechanisms between endometriosis and ovarian cancer.

Authors:  Qingsong Meng; Weixue Sun; John Jiang; Nicole M Fletcher; Michael P Diamond; Ghassan M Saed
Journal:  J Assist Reprod Genet       Date:  2011-05-26       Impact factor: 3.412

4.  Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Xin Huang; Esther Elishaev; Raluca A Budiu; Lixin Zhang; SungHwan Kim; Nicole Donnellan; Gina Mantia-Smaldone; Tianzhou Ma; George Tseng; Ted Lee; Suketu Mansuria; Robert P Edwards; Anda M Vlad
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

5.  Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery?

Authors:  Hazel B Nichols; Kala Visvanathan; Polly A Newcomb; John M Hampton; Kathleen M Egan; Linda Titus-Ernstoff; Amy Trentham-Dietz
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

6.  Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.

Authors:  Zhen Zhen Zhao; Pamela M Pollock; Shane Thomas; Susan A Treloar; Dale R Nyholt; Grant W Montgomery
Journal:  Hum Reprod       Date:  2008-02-18       Impact factor: 6.918

7.  Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: no association with advanced endometriosis.

Authors:  Yeon Jean Cho; Sung Eun Hur; Ji Young Lee; In Ok Song; Hye-Sung Moon; Mi Kyoung Koong; Hye Won Chung
Journal:  J Assist Reprod Genet       Date:  2007-06-12       Impact factor: 3.412

Review 8.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

9.  Shift work, hCLOCK T3111C polymorphism, and endometriosis risk.

Authors:  Jennifer L Marino; Victoria L Holt; Chu Chen; Scott Davis
Journal:  Epidemiology       Date:  2008-05       Impact factor: 4.822

10.  Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma.

Authors:  Snezana Pejić; Ana Todorović; Vesna Stojiljković; Jelena Kasapović; Snezana B Pajović
Journal:  Reprod Biol Endocrinol       Date:  2009-12-23       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.